 |
|
Symposia Sessions: March 12 |
March 13 |
March 14
|
|
Infection Control in Low-Resource Settings: Recognizing the Need
Co-Chairs: Richard Wenzel, USA; Wing Hong Seto, CHINA
Tuesday, March 12, 2002 11:00-13:00
- Nosocomial Infections and Infection Control: Contrasting Perspectives from Developed vs. Developing Countries
Richard Wenzel (USA)
- Minimizing Surgical Site Infections in Low-Resource Settings
Mike Whitby (AUSTRALIA)
- The Contribution of Infection Control to Managing Antibiotic Resistance
Moi-Lin Ling (SINGAPORE)
- Relative Contributions of Technology and Behavior Changes for Infection Control Outcomes
Wing Hong Seto (CHINA)
Complete Genome Sequencing: What Does it Teach Us?
Co-Chairs: Didier Raoult, FRANCE; Keryn Christiansen, AUSTRALIA
Tuesday, March 12, 2002 11:00-13:00
- Comparative Genomics of Bartonella henselae and Bartonella quintana
Siv Andersson (SWEDEN)
- Neisseria meningitidis
Rino Rappuoli (ITALY)
- Gene Expression and Functional Analysis with Mycoplasma pneumoniae
Richard Herrmann (GERMANY)
- Rickettsia conorii versus Rickettsia prowazekii: Lessons of Comparative Genomics
Jean-Michel Claverie (FRANCE)
New Trends in Fungal Infections
Co-Chairs: Vladimir Krcmery, SLOVAKIA; Slavko
Schonwald, CROATIA
Tuesday, March 12, 2002 11:00-13:00
- Emerging Invasive Fungal Infections in Children and Adults
Vladimir Krcmery (SLOVAKIA)
- Preventive Strategies vs. Preemptive Therapy: Fungal Infection
in the Surgical ICU
Jorge Garbino (SWITZERLAND)
- Management of Penicilliosis in Southeast Asia
Thira Sirisanthana (THAILAND)
- Management of Fungal Infection in HIV Patients Without Access
to HAART
Murat Akova (TURKEY)
- Overview of Echinocandin Activity in the Treatment of Fungal Infections
Johan Maertens (BELGIUM)
Recent Advances in the Treatment of Chronic Hepatitis B Infection
Co-Chairs: John S. Tam, CHINA; David Mutimer, UNITED KINGDOM
Tuesday, March 12, 2002 11:00-13:00
- Present and Future Treatments of Chronic Hepatitis B Infection: An Update
Nancy W.Y. Leung (CHINA)
- Antiviral Therapy for Hepatitis B Virus Infection in Liver Transplantation
David Mutimer (UNITED KINGDOM)
- Hepatitis B Virus Mutations and Antiviral Treatment
William F. Carman (UNITED KINGDOM)
- Treatment Options for HBV-Associated Decompensated Liver Diseases
E. Jenny Heathcote (CANADA)
- Immune Therapy of Hepatitis B Virus Chronic Infection
Stanislas Pol (FRANCE)
Appropriate Use of Antibiotics and Its Impact on Resistance Development
Co-Chairs: Stephen Zinner, USA; Kwen-Tay Luh, TAIWAN
Tuesday, March 12, 2002 11:00-13:00
- Globalization of Antimicrobial Resistance-epidemiological Challenges
Donald Low (CANADA)
- Infectious Disease/Population Dynamics Perspective: Consequences of Action and Inaction
Bruce Levin (USA)
- PK/PD Perspective: Does Dose Matter?
Richard Wise (UNITED KINGDOM)
- Physician's Perspective: Life at the Sharp End of Prescribing
William Holmes (UNITED KINGDOM)
Confronting Pediatric HIV/AIDS Globally
Co-Chairs: Connie Osborne, SWITZERLAND; Chia-Yin Chong, SINGAPORE
Tuesday, March 12, 2002 11:00-13:00
- The Treatment of Pediatric HIV in Low-Resource Settings
Connie Osborne (SWITZERLAND)
- Strategies for Initial Therapies and Late Modifications in Children Infected with HIV
Jack Levy (BELGIUM)
- Low Cost Antiretroviral Treatments to Prevent Maternal-to-Child Transmission of AIDS
Philippe Lepage (BELGIUM)
- Enabling AIDS Orphans to Achieve Healthy Productive Adulthood: Affordable Strategies that Work
Matthew Hodge (USA)
Sexually Transmitted Diseases
Co-Chairs: King Holmes, USA; Allan Ronald, CANADA
Tuesday, March 12, 2002 11:00-13:00
- Changing Epidemiology with Emphasis on N. gonorrhoeae
Kai Man Kam
- Understanding the HSV-2 and HIV Interaction
Connie Celum (USA)
- M. genitalium: An Emerging Newly Recognized Pathogen
Tony Cunningham (AUSTRALIA)
- Training Pharmacists to Manage and Prevent STD's - A Health Services RCT from Peru
King Holmes (USA)
Vaccination of the Millennium Babies
Chair: Stanley Plotkin, USA; Tan Cheng Lim, SINGAPORE
Tuesday, March 12, 2002 11:00-13:00
- Poliomyelitis: Choosing the Right Vaccine for Safer Protection
Jacob John (INDIA)
- Acellular Pertussis Combined Vaccines: Vaccines of the Future
Michael Decker (USA)
- MMR Vaccination: Current Situation and Perspectives
Stanley Plotkin (USA)
- Vaccinating Children Against Influenza — Protecting Individuals and Communities
David Fedson (FRANCE)
Practical Issues in Emerging Infections
Co-Chairs: Ai Ee Ling, SINGAPORE; Helen Oh, SINGAPORE
Tuesday, March 12, 2002 15:00-17:00
- Emergence of Nipah Virus: How it Happened! Will We Have Another Epidemic?
Kaw Bing Chua (MALAYSIA)
- Enterovirus 71: How and Why Epidemics Occur
Tzou-Yien Lin (TAIWAN)
- Crisis on the Border: Rift Valley Fever Outbreak in Saudi Arabia and Yemen
Tariq Ahmed Madani (SAUDI ARABIA)
- Containing Hemorrhagic Fever Epidemics: The Ebola Experience in Uganda
Margaret Lamunu (UGANDA)
New Frontiers in the Management of Chronic Hepatitis C: Therapeutic Innovations and Clinical Benefits
Co-Chairs: Gloria Taliani, ITALY; Richard Guan,
SINGAPORE
Tuesday, March 12, 2002 15:00-17:00
- Diagnosis and Monitoring of HCV Infection
Evangelista Sagnelli (ITALY)
- The Efficacy of Antiviral Therapy for Prevention of Hepatocellular Carcinoma and Improvement in Mortality
Masao Omata (JAPAN)
- Which Treatment for Patients with HCV Infection and Compensated Cirrhosis
E. Jenny Heathcote (CANADA)
- Mechanisms of Antiviral Treatment and Possible Reasons for Failure in Chronic Hepatitis C Virus Infection
Howard C. Thomas (UNITED KINGDOM)
Health Impact of Foodborne Pathogens
Co-Chairs: Robert Tauxe, USA; Hannes Pichler, AUSTRIA
Tuesday, March 12, 2002 15:00-17:00
- Non-typhoid Salmonella as a Foodborne Pathogen
Sayomporn Sirinavin (THAILAND)
- The Public Health Impact of Campylobacter
Robert Tauxe (USA)
- An Emerging Foodborne Pathogen: Bovine Spongiform Encephalopathy
Maura Ricketts (SWITZERLAND)
- E. coli 0157: H7: Understanding a Potentially Deadly Food Borne Disease
Haruo Watanabe (JAPAN)
Truth or Coincidence: Chronic Sequelae of Infectious Diseases
Co-Chairs: Jean-Paul Butzler, BELGIUM; Jean-Claude Pechère, SWITZERLAND
Tuesday, March 12, 2002 15:00-17:00
- Campylobacter jejuni and Guillain-Barré Syndrome
Nobuhiro Yuki (JAPAN)
- Hemolytic Uremic Syndrome and E. coli
Yoshifumi Takeda (JAPAN)
- The Hypothetical Association between Multiple Sclerosis and Infection
Jean-Claude Pechère (SWITZERLAND)
- Helicobacter pylori and Cancer
Martin J. Blaser (USA)
- Atherosclerosis and Chlamydia pneumoniae
Sandeep Gupta (UNITED KINGDOM)
Ketolides as Potential Therapeutic Agents in Areas of High Prevalence of Antibiotic Resistance
in S. pneumoniae
Chair: Daryl Hoban, CANADA, André Bryskier,
FRANCE
Tuesday, March 12, 2002 15:00-17:00
- Prevalence of S. pneumoniaeResistance to Beta Lactams, Macrolides and
Fluoroquinolones in the Far East
Mitsuo Kaku (JAPAN)
- What Drives Resistance? - Social, Economic, and Political Factors
John Mcgowan (USA)
- How Pharmacokinetics and Pharmacodynamics Determine Outcome
- Have We Learned Any Lessons?
David Nicolau (USA)
- Macrolide Resistance in Streptococcus pneumoniae: Implications for Ketolides
Daryl Hoban (CANADA)
- Therapeutic Efficacy of New Agents Against Resistant Bacteria ñ How do Ketolides Compare?
Ralf Réné Reinert (GERMANY)
Prevention of Haemophilus influenzae Disease in Asia: Country and Regional Experiences to Guide Vaccine Introduction
Co-Chairs: Kim Mulholland, AUSTRALIA; Joel I. Ward, USA
Tuesday, March 12, 2002 15:00-17:00
- Global Importance of Preventing Haemophilus influenzae type b Disease
Joel I. Ward (USA)
- Incidence of Haemophilus influenzae Type b (Hib) Meningitis in Two Provinces of Thailand 2000-2001
Sophie Treleaven (UNITED KINGDOM)
- Epidemiologic Population-based Surveillance for Hib Disease in China, Korea and Vietnam
Paul Kilgore (REPUBLIC of KOREA)
- The Proportion of Radiologically-confirmed and Other Pneumonias Due to Haemophilus influenzae type b on Lombok Island, Indonesia, Using Haemophilus influenzae type b Conjugate Vaccine as a Probe: Status Report
Agustinus Sutanto (INDONESIA)
- Programmatic Considerations and Paradigms for Hib Vaccine Introduction in Asia
Jay Wenger (SWITZERLAND)
- Summary and Future Directions
Kim Mulholland (AUSTRALIA)
 return to top
|
A New Approach Against Pandemics
Co-Chairs: Ai Ee Ling, SINGAPORE; Helen Oh, SINGAPORE
Wednesday, March 13, 2002 11:00 - 13:00
- Flu Situation in South East Asia
Ai Ee Ling (SINGAPORE)
- Pandemics - Past and Future
Karl Nicholson (UNITED KINGDOM)
- Clinical Experience with an Adjuvanted Influenza Vaccine - First
Choice Flu Vaccine for Elderly
Audino Podda (ITALY)
- Cost Effectiveness of Influenza Vaccination
James Piercy (UNITED KINGDOM)
The Global Threat of Dengue — Desperately Seeking Solutions
Co-Chairs: Vincent Chow, SINGAPORE; Maria G. Guzmán,
CUBA
Wednesday, March 13, 2002 11:00-13:00
- Epidemic Dengue/Dengue Hemorrhagic Fever as a Global Public
Health Problem in the 21st Century
Duane J. Gubler (USA)
- New Developments and Challenges in the Diagnosis of Dengue
María G. Guzmán (CUBA)
- Determinants of Dengue Viral Virulence
Vincent Chow (SINGAPORE)
- Targeting the Pre-Membrane and Envelope Antigens to MHC Class
II Compartment Enhances Neutralizing Antibody Response to a Dengue
DNA Vaccine
Thomas August (USA)
Emerging Infections: The Strategy for Identifying New Pathogens
Co-Chairs: Didier Raoult, FRANCE; Carl Erik Nord, SWEDEN
Wednesday, March 13, 2002 11:00-13:00
- The Role of Electron Microscopy
Alan Curry (UNITED KINGDOM)
- The Role of Culture
Didier Raoult (FRANCE)
- The Role of Serology
Matti Valtonen (FINLAND)
- The Role of Molecular Biology
David Relman (USA)
New Challenges in Tuberculosis Control
Co-Chairs: Timothy Brewer, USA; Thelma Tupasi, PHILIPPINES
Wednesday, March 13, 2002 11:00-13:00
- The Role of Molecular Epidemiology in the Evaluation of Tuberculosis Control Efforts
Dao Nguyen (CANADA)
- Management of MDR-TB in a Low-Resource National Program
Eduardo Gotuzzo (PERU)
- Treatment of Latent TB Infection for TB Control in HIV-Endemic Settings
Alwyn Mwinga (ZAMBIA)
- Beyond National Programs: The Role of Private and Non-Profit Organizations in TB Control
Mukund Uplekar (SWITZERLAND)
The Global Extension of Care for Persons with HIV/AIDS
Co-Chairs: Pierce Gardner, USA; N. Kumarasamy, INDIA
Wednesday, March 13, 2002 11:00-13:00
- Challenges and Opportunities to the Global Implementation of HIV Prevention and Treatment Programs
Harold Jaffe (USA)
- Introducing Widespread HIV/AIDS Treatment: Implications for
the Emergence of Antiretroviral Resistance
Roy Anderson (UNITED KINGDOM)
- Making HIV Prevention and Treatment Work on a National Scale: Lessons from Uganda
Peter Mugyenyi (UGANDA)
- Global AIDS Care and Prevention in a Low Resource Setting: How
Does It Happen?
Jean W. Pape (HAITI)
Pertussis Beyond Childhood: Meeting the Need to Boost
Co-Chairs: Hans Bock, SINGAPORE; Heng Kock Cheng,
SINGAPORE
Wednesday, March 13, 2002 11:00-13:00
- Pertussis: The Underestimated Disease
James Cherry (USA)
- Acellular Pertussis Vaccines for Use beyond Childhood
Jussi Mertsola (FINLAND)
- dTpa Booster Vaccination of 4-6 Year-Old DTPw-Primed Subjects
Yong Poovorawan (THAILAND)
- Booster Vaccination at 4-6 Years in DTPa-Primed Children
Terry Nolan (AUSTRALIA)
- Recommendation for Pertussis Vaccination
C.H.Wirsing Von König (GERMANY)
Strategies to Help Control the Growing Global Threat of Antibiotic Resistance in Hospital-Acquired Infections
Chair: Victor K.E. Lim, MALAYSIA
Wednesday, March 13, 2002 11:00-13:00
- The Growing Problem of Resistance in the Hospital Setting in
the Asia Pacific
Jae-Hoon Song (REPUBLIC OF KOREA)
- The Growing Problem of Gram-Negative Resistance in the Hospital
Setting and Strategies to Help Minimize the Problem
James Tan (USA)
- Gram-Positive Resistance–How Bad is the Problem and What
is There to Do to Control It?
Lance Peterson (USA)
New Strategies for the Management of Bone, Joint, and Prosthetic Infections—New Approaches to Old Problems
Co-Chairs: Daniel Lew, SWITZERLAND; Francis Waldvogel, SWITZERLAND
Wednesday, March 13, 2002 15:00-17:00
- Pathophysiology and Novel Medical Therapeutic Modalities of Prosthetic Joint Infections
Daniel Lew (SWITZERLAND)
- Diabetic Foot Infection
AW Karchmer (USA)
- Evidence-Based Approach to the Use of Local and Oral Antibiotics in Chronic Osteomyelitis
Tony Berendt (UNITED KINGDOM)
- Where Zebras Tread: Management of Chronic Tropical Osteomyelitis
Philip A. Thomas (INDIA)
Mechanisms of Antibiotic Resistance
Co-Chairs: Jacques Acar, FRANCE; Awa Kane-Aïdara, SENEGAL
Wednesday, March 13, 2002 15:00-17:00
- Multiple Antibiotic Resistance: Bacterial Advantages and Risks in the Clinical Setting
Keryn Christiansen (AUSTRALIA)
- Overcoming Resistance in Gram-positive Pathogens: The Role of Antibiotic Combinations
Philippe Moreillon (SWITZERLAND)
- Understanding the Bacterial Cell Wall: New Enzymatic Pathways, New Resistances, and New Targets for Antibiotics
Joachim-Volker Hoeltje (GERMANY)
- Diversity of Beta-Lactamases: What is the Future for Beta-Lactamase Inhibitors?
Patrice Nordmann (FRANCE)
The Potential Global Impact of the Pneumococcal Conjugate Vaccines
Co-Chairs: Ron Dagan, ISRAEL; Keith Klugman, USA
Wednesday, March 13, 2002 15:00-17:00
- Efficacy and Effectiveness of Pneumococcal Conjugate Vaccines - Global Perspectives
Keith Klugman (USA)
- Carriage, Transmission and Spread of S. pneumoniae: The Impact of Conjugate Vaccines
Ron Dagan (ISRAEL)
- The Global Acceptance and Availability of Pneumococcal Conjugate Vaccines for the First Decade of the 21st Century
Kim Mulholland (AUSTRALIA)
Melioidosis
Co-Chairs: Brenda Ang, SINGAPORE; Mahbubur Rahman, BANGLADESH
Wednesday, March 13, 2002 15:00-17:00
- Melioidosis: Pathogenesis and Clinical Features
Nicholas J. White (THAILAND)
- Molecular Detection of Burkholderia pseudomallei
May Ann Lee (SINGAPORE)
- Other than Humans-Melioidosis in Animals
Paolo Martelli (SINGAPORE)
- Treatment of Melioidosis - Where Are We Now?
Yupin Suputtamongkol (THAILAND)
New Advances in Antiretroviral Therapy for HIV
Co-Chairs: Pedro Cahn, ARGENTINA; Kiat Ruxurungtham, THAILAND
Wednesday, March 13, 2002 15:00-17:00
- When Should You Initiate Antiretroviral Therapy?
Pedro Cahn (ARGENTINA)
- Blood Monitoring of Antiretroviral Drug Levels: Their Role in Clinical Practice
John G. Gerber (USA)
- Antiretroviral Toxicities: Recognition and Management
Andrew Carr (AUSTRALIA)
- Antiviral Treatment Strategies for HIV-1 Disease: Virologic, Immunologic and Clinical Effects of Treatment Interruptions
Veronika Miller (USA)
Controversies in the Management of Lower Respiratory Tract Infections
Chair: Thomas File, USA, Yoshihito Niki, JAPAN
Wednesday, March 13, 2002 15:00-17:00
- Chlamydia and Mycoplasma: Do They Matter?
Francesco Blasi (ITALY)
- Prevalence of Atypical Respiratory Pathogens in Asia —
Plans for a Surveillance Study
Yuet-Meng Cheong (MALAYSIA)
- What is the Impact of Pneumococcal Resistance
Guy Amsden (USA)
- RTI Guidelines - East Versus West
Thomas File (USA), Yoshhito Niki (JAPAN)
New Advances in Clinical Microbiology
Co-Chairs: Augustine Cheng, CHINA, Javier Garau
(SPAIN)
Wednesday, March 13, 2002 15:00-17:00
- Microbial Signaling and Pathogenicity
Andreas Podbielski (GERMANY)
- Microarray-Based Mutational Analysis: Genetic Basis for Predisposition and Resistance to Disease
Calvin C.P. Pang (CHINA)
- Low-Density Microarrays: A Flexible Tool for Clinical Diagnostics
Tim Tiemann (USA)
- Diagnosis, Sensitivity Testing and Identification of Stage of Disease in Tuberculosis-Applications of Reporter Technology
Neeraj Dhar (INDIA)
return to top
|
Partnerships for Containing Antimicrobial Resistance: The WHO Global Strategy in Action in Low-Resource Countries
Co-Chairs: Atef Shibl, SAUDI ARABIA; Po-Ren Hsueh,
TAIWAN
Thursday, March 14, 2002 11:00-13:00
- The Role of WHO in Coordinating a Global Response to Antibiotic Resistance
Lindsay Grayson (AUSTRALIA)
- National Strategies to Reduce Irrational Use of Antimicrobials to Decrease Costs and Antimicrobial Resistance
Daniel Lew (SWITZERLAND)
- Drug Policy and Essential Drugs: What is Their Impact in Preventing
and Controlling Antimicrobial Resistance?
Kathy A. Holloway (SWITZERLAND)
- International Societies and Antimicrobial Resistance: Bridging Global Policy and Local Actions
King Holmes (USA)
HIV in the Asian Pacific Region
Co-Chairs: Yee Sin Leo, SINGAPORE; Christopher Lee, MALAYSIA
Thursday, March 14, 2002 11:00-13:00
- Epidemiology of HIV and AIDS in the Asian Pacific Region
Christopher Lee (MALAYSIA)
- Accessibility of Care and Treatment of HIV and AIDS in the Asian Pacific Region
Nicholas Paton (SINGAPORE)
- Antiretroviral Therapy in Resource-Limited Settings: The Thai Experience
Kiat Ruxurungtham (THAILAND)
- Managing Opportunistic Infections in Resource-Limited Areas
Roberto Badaró (BRAZIL)
Infectious Diseases as Weapons: Bioterrorism and Public Health
Co-Chairs: Alasdair Geddes, UNITED
KINGDOM; Richard Wenzel, USA
Thursday, March 14, 2002 11:00-13:00
- Infectious Organisms as Biological Weapons: Which Ones Do We
Need to Worry About and Why?
Richard Wenzel (USA)
- The Public Health Response to an Anthrax Attack: Maximizing
Control while Minimizing Confusion
Nina Marano (USA)
- An Additional Threat to Global Health Security: The Use of Biological
Agents to Cause Harm
Ottorino Cosivi (SWITZERLAND)
New Understandings in the Pathophysiology and Treatment of Bacterial
Meningitis
Co-Chairs: Carla Odio, COSTA RICA; Salah A. Ibrahim, SUDAN
Thursday, March 14, 2002 11:00-13:00
- The Changing Pneumococcal Surface: Invasion and Virulence
Elaine Tuomanen (USA)
- Bacterial Translocation of the Brain-Blood Barrier
Kwang Sik Kim (USA)
- Present and Future of Adjuvant Therapy for Bacterial Meningitis
Joerg R. Weber (GERMANY)
- Fluid Restriction and Intracranial Pressure During Bacterial
Meningitis: To Restrict Fluids or Not
Sunit Singhi (INDIA)
- Current Antimicrobial Therapy for Bacterial Meningitis
Carla Odio (COSTA RICA)
Antibiotic Use in Pediatric Respiratory Infections: Changes in Risks, Attitudes, and Guidelines in the New Millennium
Co-Chairs: Chia-Yin Chong, SINGAPORE; Ken Mcintosh, USA
Thursday, March 14, 2002 11:00-13:00
- The Emergence of Resistance in Respiratory Bacterial Pathogens and the Relation to Antibiotic Use
Ron Dagan (ISRAEL)
- The Judicious Use of Antibiotics in Pediatrics: A New Initiative by the American Academy of Pediatrics and the Centers for Disease Control
Scott Dowell (THAILAND)
- Responsible Antimicrobial Treatment of Childhood Respiratory Infections - Choice of Agent and Length of Treatment
Heikki Peltola (FINLAND)
- Changes in Antibiotic Use in Pediatrics with Widespread Use of Conjugated Bacterial Vaccines
Kim Mulholland (AUSTRALIA)
- The WHO Campaign for Management of ARI: Its Effect on Antibiotic Resistance
Jacob John (INDIA)
Immunomodulators and Combination Therapy for Hepatitis C
Co-Chairs: Roger G. Finch, UNITED KINGDOM, Lim
Seng Gee (SINGAPORE)
Thursday, March 14, 2002 11:00-13:00
- New Combination Regimens for Difficult-to-Treat Chronic Hepatitis C Patients
Stefan Zeuzem (GERMANY)
- Which Patients Could Benefit from PEG Interferon plus Ribavirin Combination?
Giovanni B. Gaeta (ITALY)
- Pegylated Interferons in the Treatment of HCV/HIV Coinfected Patients
Teresa Santantonio (ITALY)
- Preventing Histologic Progression in Patients with Chronic Hepatitis C Virus Infection with Maintenance Therapy Utilizing Peginterferon: The NIH HALT-C Trial
Mitchell Shiffman (USA)
Vaccines — New Development
Co-Chairs: Jingoro Shimada, JAPAN; Dennis Kasper, USA
Thursday, March 14, 2002 11:00-13:00
- New Developments in Inactivated and Live Influenza Vaccines
John Treanor (USA)
- Vaccines Against Group B Streptococcus - A Serious Neonatal Pathogen
Dennis Kasper (USA)
- Immunologic and Viral Challenges to Developing an HIV Vaccine
Mitsuo Honda (JAPAN)
- DNA Vaccines Against Japanese Encephalitis and Dengue
Eiji Konishi (JAPAN)
Update on Anaerobes
Co-Chairs: Andrew B. Onderdonk, USA; Pramod Shah, GERMANY
Thursday, March 14, 2002 13:00-15:00
- The Role of Immunomodulators in Sepsis
Arthur O. Tzianabos (USA)
- New Antimicrobial Therapy for Anaerobic Infections
Carl Erik Nord (SWEDEN)
- The Potential Role of Intestinal Microflora in the Development
of Childhood Allergies
Bengt Björksten (SWEDEN)
- Update on Clostridium difficile and Antibiotic Associated
Colitis
Arne Rodloff (GERMANY)
Problems and Progress in Malaria Treatment and Prevention in South East Asia
Co-Chairs: Nicholas Paton, SINGAPORE; Kamini N. Mendis, SWITZERLAND
Thursday, March 14, 2002 15:00-17:00
- Malaria on Islands: Evolutionary Approaches to Control
Akira Kaneko (JAPAN)
- New Agents for Malaria Treatment and Prophylaxis
Sornchai Looareesuwan (THAILAND)
- Chloroquine-Resistant Vivax: Epidemiology and Treatment Options
Kevin Baird (USA)
- How Close is an Effective Malaria Vaccine?
(speaker to be confirmed)
Vaccine Preventable Diseases — Successes and Ongoing Challenges
Co-Chairs: Heikki Peltola, FINLAND; Frank Shann, AUSTRALIA
Thursday, March 14, 2002 15:00-17:00
- Global Magnitude of Vaccine Preventable Mortality in Children
Frank Shann (AUSTRALIA)
- What do Children Gain from Pneumococcal and Hib Conjugates?
Heikki Peltola (FINLAND)
- 20 Years of Experience in Hepatitis B Vaccination
Francis Andre (BELGIUM)
- New Vaccines, New Approaches: What EPI Should be Doing to Further Reduce Vaccine Preventable Diseases Over the Next Five Years
Ken Mcintosh (USA)
Towards Controlling Antimicrobial Use and Resistance in Low-Income
Countries
Co-Chairs: Franco Paradisi, ITALY; Anibal Sosa,
USA
Thursday, March 14, 2002 15:00-17:00
- Epidemiology of Antimicrobial Resistance in Low-Income Countries
Eduardo Gotuzzo (PERU)
- Factors Involved in the Emergence and Diffusion of Antimicrobial Resistance in Low-Income Countries
Alessandro Bartoloni (ITALY)
- Detecting Antibiotic Resistance in Low-Resource Settings
John Turnidge (AUSTRALIA)
- Rational Antibiotic Use in Low-Resource Settings: Practices and Policies that Work
Atef Shibl (SAUDI ARABIA)
- APUA Country-specific Antibiotic Regulation Strategy: Lessons Learned in Latin America, the Caribbean and the Importance of the Guadalajara Declaration
Anibal Sosa (USA)
Update on Biomedical Interventions to Prevent HIV Transmission
Co-Chairs: Kenneth H. Mayer, USA; Soh Ha Chan,
SINGAPORE
Thursday, March 14, 2002 15:00-17:00
- The Search for an Anti-HIV Vaccine
Jose Esparza (SWITZERLAND)
- Treating STDs to Decrease HIV Transmission
Allan Ronald (CANADA)
- Topical Microbicides to Decrease HIV Transmission
Salim Abdool Karim (SOUTH AFRICA)
- The Use of Antiretroviral Therapy (ART) to Decrease HIV Transmission
Kenneth H. Mayer (USA)
Pandemic Influenza: From Molecular Pathogenesis to Global Preparedness
Co-Chairs: Klaus Stöhr, SWITZERLAND; Nobuhiko Okabe, JAPAN
Thursday, March 14, 2002 15:00-17:00
- Influenza Pandemics and Epidemics
Yoshihiro Kawaoka (JAPAN)
- Antiviral Therapy: What to Use and When for Prevention and Treatment of Influenza
Arnold Monto (USA)
- Pandemic Influenza and the Global Vaccine Supply
David Fedson (FRANCE)
- How is the Global Public Health Community Prepared for the Next Pandemic?
Klaus Stöhr (SWITZERLAND)
return to top
|
|
|
|
|
|
